company leadership

Company Leadership

Back to Company Leadership
Robin Kenselaar

Current Role(s): Head of Europe, Middle East and Africa

Joined: 2004



Robin Kenselaar has overall responsibility for Genzyme’s business in EMEA (Europe and ITC). He provides strategic direction to further develop Genzyme’s presence in these regions, which includes product launches in both Rare Diseases and Multiple Sclerosis in our European core markets, as well as opening new markets in the ITC region. There are about 1,300 employees on the EMEA team, operating in the markets across Europe and ITC.

Prior experience:

  • General Manager of Genzyme Netherlands
  • Business Unit Director, Personalized Genetic Health, Genzyme
  • Head of the European Financial Planning and Analysis Group, Genzyme
  • Director of International Business Operations, Genzyme
  • Various leadership positions at Rockwell International
  • Board member, Biofarmind (Dutch biotech Association)  

Education:

  • M.B.A., Nyenrode University (Netherlands)
  • B.B.A., Nyenrode University (Netherlands)
Last Updated: 4/5/2016
infoBox